Citation Impact

Citing Papers

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism
2005 StandoutNobel
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Can the immune response control HIV infection?
1995
Photoreceptor preservation in the S334ter model of retinitis pigmentosa by a novel estradiol analog
2004
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 Standout
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
2000 Standout
Hepatitis C Virus Infection
2001 Standout
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline
2008
Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection
1995
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
Association between Culturable Human Immunodeficiency Virus Type 1 (HIV‐1) in Semen and HIV‐1 RNA Levels in Semen and Blood: Evidence for Compartmentalization of HIV‐1 between Semen and Blood
1998
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
AIDS DEMENTIA COMPLEX
1999
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
2001 StandoutScience
SIVagm genetic and biological features associated with replication
2003
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Global cancer statistics
2011 Standout
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
2004
KSHV (HHV8) Infection
2000
Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990
1996
Mechanisms of HIV/SIV Mucosal Transmission
1994
Retinitis pigmentosa
2006 Standout
Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place
2008
Host factors in the pathogenesis of HIV disease
1997
Comprehensive Analyses of a Unique HIV-1-Infected Nonprogressor Reveal a Complex Association of Immunobiological Mechanisms in the Context of Replication-Incompetent Infection
2002
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV‐1‐infected patients
2004
HCV epidemiology in high-risk groups and the risk of reinfection
2016
Immunologic and Virologic Status after 14 to 18 Years of Infection with an Attenuated Strain of HIV-1 — A Report from the Sydney Blood Bank Cohort
1999
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
2011
HIV as the cause of AIDS
1996 StandoutNobel
Progress towards elimination goals for viral hepatitis
2020
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2008 StandoutNobel
Long-term survivors of HIV-1 infection
1995
Myocarditis
2000 Standout
Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection
1996
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
1995 StandoutNature
HIV fusion and its inhibition
2001
Changing Virus‐Host Interactions in the Course of HIV‐1 Infection
1994
Immunological recovery and antiretroviral therapy in HIV-1 infection
2006
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Cervical cancer
2019 Standout
Absence of Recoverable Infectious Virus and Unique Immune Responses in an Asymptomatic HIV + Long-Term Survivor
1994
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
1995
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
How Does HIV Cause AIDS?
1993 Science
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
2012 Nature
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Increased Macrophage Infection upon Subcutaneous Inoculation of Rhesus Macaques with Simian Immunodeficiency Virus-Loaded Dendritic Cells or T Cells but Not with Cell-Free Virus
2002 StandoutNobel
Herpesviruses as Co-Factors of HIV Disease: Case not Proven
1995
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Coupling of the expressed alpha 1B-adrenergic receptor to the phospholipase C pathway in Xenopus oocytes. The role of Go.
1993 StandoutNobel
Simian Immunodeficiency Virus (SIV)gagDNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection
2000
Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients
1995 Science
Molecular mimicry: Can epitope mimicry induce autoimmune disease?
1997
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Pathogenesis of human immunodeficiency virus infection
1993
Evidence for host-cell selection of influenza virus antigenic variants
1983 Nature
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Polyoxometalates in Medicine
1998 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Toward an Understanding of the Correlates of Protective Immunity to HIV Infection
1996 Science
Laboratory diagnostics for HIV infection.
2010
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
1996 StandoutScience
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Global cancer statistics, 2012
2015 Standout
Characterization of CD4+ CTLs Ex Vivo
2002
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
2000
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Prospects for the Future
2002 StandoutScienceNobel
Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids
1998
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
2003 StandoutNobel
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
2004

Works of Philip Cunningham being referenced

Levels of Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid Correlate with AIDS Dementia Stage
1997
Patterns of Viral Dynamics during Primary Human Immunodeficiency Virus Type 1 Infection
1998
Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection
2000
Increased Turnover of CCR5+and Redistribution of CCR5CD4 T Lymphocytes during Primary Human Immunodeficiency Virus Type 1 Infection
2001
Administration of Imiquimod, an Interferon Inducer, in Asymptomatic Human Immunodeficiency Virus‐Infected Persons to Determine Safety and Biologic Response Modification
1998
Phenotypic Analysis of CD8+ T Lymphocytes in a Cohort of HIV Type 1-Infected Patients Treated with Saquinavir, Ritonavir, and Two Nucleoside Analogs for 1 Year, and Association with Plasma HIV Type 1 RNA
1999
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
2017
Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid
2000
Identification of HIV-1 in semen following primary HIV-1 infection
1992
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor
1992
Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations
2004
Kaposi's Sarcoma-Associated Herpesvirus: A Sexually Transmissible Infection?
1999
Safety and Immunogenicity of UBI HIV-1 MN Octameric V3 Peptide Vaccine Administered by Subcutaneous Injection
1997
Docking Studies Show That D-Glucose and Quercetin Slide through the Transporter GLUT1
2005
Potent Antiretroviral Therapy of Primary Human Immunodeficiency Virus Type 1 (HIV‐1) Infection: Partial Normalization of T Lymphocyte Subsets and Limited Reduction of HIV‐1 DNA Despite Clearance of Plasma Viremia
1999
Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
1996
The use of a continuous cell line for the isolation of influenza viruses.
1978
Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis.
1995
Multisite Evaluation of Four Anti-HIV-1/HIV-2 Enzyme Immunoassays
1995
Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis
2017
Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995–1997
2000
Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1
2002
Influenza in the United Kingdom 1982–85
1986
Rankless by CCL
2026